Cholesterol helps a platinum drug reach deep into tumors
A new nanodrug uses cholesterol to bypass barriers created by cancer associated fibroblasts.
Surface-displayed cholesterol improves how a platinum nanodrug penetrates and fights tumors. This drug is called PtD-Chol.
Cancer associated fibroblasts (CAF) can act as a physical barrier for drug delivery. These cells are found in stroma-rich tumors.
PtD-Chol targets NPC1L1-expressing cancer associated fibroblasts. It uses a shared entry portal of NPC1L1 to trigger cross-multicellular transport (CMCT).
CMCT shuttles PtD-Chol across the CAF barrier. It moves through the endocytic recycling compartment-endoplasmic reticulum-Golgi pathway to enable deep penetration.
In female mice, PtD-Chol restores efficacy in refractory tumor models. It suppresses primary growth and CAF-driven metastasis by remodeling the tumor microenvironment.
Key facts
- PtD-Chol uses surface-displayed cholesterol to target NPC1L1-expressing cancer associated fibroblasts.
- The drug uses cross-multicellular transport (CMCT) to move through the CAF barrier.
- This method suppresses primary growth and CAF-driven metastasis in female mice.